Table 1 Self-medication with anti-malarial drugs prior to consultation in Terinkyo and Madibou health centres in Makelekele district, Brazzaville
Anti-malarial drugs | N (%) |
|---|---|
Patients | 1,087 |
No self-medication | 823 (75.7) |
After self-medication | 264 (24.3) |
Classical monotherapies | 237 (89.8) |
Amodiaquine | 38 (14.4) |
Chloroquine | 139 (52.7) |
Quinine | 42 (15.9) |
Sulphadoxine-pyrimethamine | 18 (6.8) |
Artemisinin derivatives | 27 (10.2) |
Artesunate monotherapy | 6 (2.3) |
Artemether monotherapy | 11 (4.2) |
Dihydroartemisinin monotherapy | 4 (1.5) |
Artemisinin-based combination therapy (ACT) | 6 (2.3) |
Artemether-lumefantrine | 1 (0.4) |
Artesunate + amodiaquine | 4 (1.5) |
Dihydroartemisinin-sulphadoxine-pyrimethamine | 1 (0.4) |